Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02032797
Other study ID # PROFETA-5
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date November 2012
Est. completion date September 2019

Study information

Verified date September 2019
Source Universitair Ziekenhuis Brussel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine whether 5 or 7 days of progesterone supplementation before transfer of a day 5 cryopreserved thawed embryos in an artificial cycle results in a significant higher pregnancy rate.


Description:

Cryopreserved-thawed embryos are often replaced in an artificial cycle, in which the endometrium is prepared by exogenous estrogen and progesterone with or without the use of GnRH agonist downregulation. The correct duration for exposure to progesterone is still not well established. To date, there are no prospective randomized trials available, comparing different durations of progesterone supplementation before the date of transfer, with regard to treatment outcome (Nawroth).

The purpose is to transfer the embryo during the 'window of implantation', what is defined as the period during which the uterus is receptive for implantation of the free-lying blastocyst. This has been a subject of debate since many years (Bourgain et al, 2007).

Succesful implantation requires a co-ordinated series of events allowing a timely dialogue between a receptive endometrium and the intrusive blastocyst (Tabibzadeh, 1998). The period of receptivity is thought to be 3 days in human (Rogers et al, 1989; Yoshinaga, 1988; Psychoyos, 1993; Harper, 1992). It is suggested that blastocyst apposition begins about day LH+6 and is completed by day LH+10 (Lessey, 2000).

A number of structural and functional endometrial changes have been suggested to play a role in the implantation process: the formation of luminal epithelial pinopodes (Enders et al, 1973), expression of adhesion molecules and growth factors and cytokines (Lessey, 2000). Most of them are related directly or indirectly to progesterone secretion and influence on the endometrium.

In the Centre of Reproductive Medicine of the Brussels University Hospital, we start progesterone supplementation 7 days before the transfer of a day 5 embryo. In order to mimic the natural cycle, since progesterone starts to rise 2 to 3 days before ovulation, due to the LH-stimulated production by the peripheral granulosa cells (Speroff). In fresh IVF-cycles, progesterone is started from the day of oocyte retrieval. HCG administration in fresh cycles will lead to an increase in progesterone levels and therefore, endometrium will progress quickly, compared with frozen-thawed cycles which are hormone supplemented (Nawroth).

Our approach in artificial FrET cycles results in a pregnancy rate of 26%.

In other centres, progesterone supplementation is generally started 5 days before the embryo transfer. Recent studies show pregnancy rates up to 40.5% (Givens CR et al, 2009), using this approach.

In this trial, we want to determine the optimal duration of progesterone supplementation.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date September 2019
Est. primary completion date September 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria:

- Artificial cycles, in which a frozen-thawed day 5 embryo is replaced.

- Signed informed consent.

- Normal transvaginal ultrasound at screening, without evidence of clinically significant abnormality consistent with finding adequate for ART with respect to uterus and adnexa.

- Embryos must be frozen by vitrification technique (cfr supra).

- Single or dual embryo transfer.

- Recipients of oocyte donation cycles may be included.

Exclusion Criteria:

- Known allergic reactions to progesterone products.

- Intake of experimental drug within 30 days prior to study start.

- Contraindication for pregnancy.

- Embryos of women above 39 years of age at the time of embryo freezing.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Progesterone


Locations

Country Name City State
Belgium Centre of Reproductive Medicine CRG Jette Brussels

Sponsors (1)

Lead Sponsor Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary clinical pregnancy rate 7 weeks of pregnancy
Secondary live birth rate 40 weeks of pregnancy
See also
  Status Clinical Trial Phase
Completed NCT04077970 - Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells Phase 3
Terminated NCT00588250 - Clinical Trial of Novel Implantation Promoting Medium (EmbryoGlue) to Improve IVF Success Rates N/A
Completed NCT03485235 - Effect of Dilatation and Curettage on the Endometrial Receptivity N/A
Recruiting NCT02072291 - Nifedipine Treatment on Uterine Contractility in IVF Phase 2
Completed NCT02815371 - Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes N/A
Completed NCT04855383 - Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles N/A
Recruiting NCT04721522 - The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
Recruiting NCT04003337 - Selection of the Embryo to Transfer by Morphokinetics vs. Morphological Evaluation. N/A
Completed NCT02407730 - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Completed NCT00635258 - Administration of GnRH Antagonist to Oocyte Donation Recipients N/A
Completed NCT03108157 - Endometrial Scratch Effect on Pregnancy Rates in Patients Undergoing Egg-donation IVF N/A
Terminated NCT04744844 - DNA Amplification in Blastocoel Fluid N/A
Active, not recruiting NCT05555121 - Rescue Progesterone Supplementation During Frozen Embryo Transfer Phase 2
Recruiting NCT04159649 - The Outcomes of ICSI Cycles With and Without Letrozole Phase 4
Not yet recruiting NCT00506480 - Assessment of Endometrial Receptivity in Recipients of Donated Oocytes N/A
Completed NCT03128970 - Synchronizing Blastocyst in Frozen Embryo Transfer N/A